4885 — Muromachi Chemicals Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual income statement for Muromachi Chemicals, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2020 May 31st	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,280	4,943	5,681	6,291	6,369
Cost of Revenue
Gross Profit	1,585	1,652	1,733	1,752	1,855
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,279	4,711	5,245	5,922	5,915
Operating Profit	1.3	232	436	369	454
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	10.6	200	426	351	469
Provision for Income Taxes
Net Income After Taxes	31.6	181	456	256	330
Net Income Before Extraordinary Items
Net Income	31.6	181	456	256	330
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31.6	181	456	256	330
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	100	83.4	112	64.1	75
Dividends per Share